Question:
What is the composition of the IET (Immuno Embryo Therapy)?
Answer:
Injection of preparation of the human placenta.
Question:
Why of the placenta namely?
Answer:
Of all human tissues, the placenta is the only tissue containing a
high concentration of the immunoblocking-activity products.
Question:
Is it a special placenta, and is it obtained in artificial
deliveries?
Answer:
Certainly not. It is obtained following physiological deliveries.
But, of course, not every placenta would be suitable, and not the
whole placenta is used, but only particular tissues thereof.
Question:
And what is the mechanism of its action?
Answer:
It is a kind of vaccine against blocking factors of tumorous
genesis. It should be pointed out that not against cancer cells, but
rather against their immunosuppressor proteins similar to those in
pregnancy. Subcutaneous administration of such preparation induces
generation of deblocking antibodies.
These antibodies, figuratively speaking, kind of
''disrobe'' the malignant cells, thus making them vulnerable to the
cytotoxic lymphocytes. This is merely a
hypotheses, and not an only one. It is possible that
antibodies suppress the factor of angiogenesis, preventing growth of
blood vessels of the tumour.
Question:
What is the procedure of preparing the preparation for
immunoembryotherapy?
Answer:
It was described in the book. Only adequate bacterial and viral
control is essential herein (like in blood transfusion).
Question:
Is individual selection of the preparation for each patient
necessary?
Answer:
It is advisable. But any placenta contains the factors inhibiting
immunity in cancer. I point out, not immunity of the host, but
immunity of the tumour.
Question:
Should anticancer vaccines be used, and how many such vaccines are
there in the world?
Answer:
Scientists have long been carrying out the related research
work, however no trustworthy results have
been obtained as yet. The cancer cells turned out to be reliably
protected. Therefore, it is necessary to first of all destroy their
protective ''armour'', and only thereafter apply specific and
nonspecific stimulators of immunity. The problem consists in the
strategy of anticancer combat. It seems likely that irradiation and
certain chemopreparations do disturb synthesis of protein in cancer
cells, therefore it seems appropriate to
use them along with IET.
Question:
Does this suggestion have anything in common with the tissue therapy
by the V.P. Filatov technique which was popular in the 50s?
Answer:
There is nothing in common. According to the Filatov technique, the
placenta was autoclaved for one hour at a temperature of 120° C,
thus completely being voided of proteins. The Filatov's teaching on
biogenic stimulators (V.P. Filatov. Selected works in 4 volumes.
Edited by the Ukrainian SSR Academy of Sciences, Kiev, 1961, Vol. 2)
does not seem applicable to the IET theory, for in this case
everything depends on the placental molecules.
Question:
Have experimental studies of placental preparations been carried
out?
Answer:
Such studies were carried out in rabbits, on the Brown-Pierce tumour
model. But the human placenta was used because of the lack of means
for such work. The results of animal studies not always can be
extrapolated to man. From the very beginning we obtained good
results on the irremediably diseased people (the appropriate
permission was obtained by the Presidium of the Scientific Council
of the Health Ministry), and therefore we did not hurry up to
increase the number of the patients, but instead carried out
long-term follow-up of our patients.
Question:
What is your attitude towards surgical treatment of cancer?
Answer:
The tumour, whenever possible, must be radically removed. Surgery is
known to have saved great many oncological patients. Even an
incomplete removal of the tumorous mass does facilitate the further
execution of the IET. Sometimes even surgery does ''deblock''
cancer. Inoperable patients, as we could be convinced, do not
respond to the IET.
Question:
And what is your attitude towards chemotherapy of cancer?
Answer:
It is difficult to answer in one word. But at the present level of
development of medicine this is inevitable. The devil of it is that
oncologists because of this trend turned out to be thinking less,
besides, no effective measures aimed at
protection of the body from chemotoxicosis have yet been
elaborated.
Question:
How long does the IET last?
Answer:
Sometimes, one massive injection turns out sufficient, we began with
that. However, our experience showed that the immediate and
short-term result (even 5 years) is not always reliable.
Question:
Can cancer be cured completely with the help of IET?
Answer:
I would not like to give an unsubstantiated answer to this question.
Here are some case studies.
